Inspiratory Muscle Training in HFpEF
ConditionHeart Failure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This study is being done to determine how inspiratory muscle training impacts inspiratory muscle function during exercise in heart failure patients.
Eligibility criteria
Qualifiers
≥18 yrs of age
Receiving SGLT2 inhibitors and spironolactone (and beta-blocker use for HFpEF patients with hypertension) for >3 months
NYHA symptoms I-III
Body mass index ≤40 kg/m2
Disqualifiers
Sustained ventricular tachycardia and/or ventricular fibrillation within 21 days of visit 1
Second or third degree heart block
Body mass index >40 kg/m2
Current smokers and/or smoking history >20 pack years
Trial design
Treatments tested in this trial
- Inspiratory Muscle Training
Treatment groups
68 Participants
are divided into 2 treatment groupsSponsors and collaborators
Mayo Clinic
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov